Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

HRTX Heron Therapeautics Inc

3,26

0,04 (1,24%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Biotech Shares Up Sharply Following Quarterly Results

A California-based biotech company is stealing the show so far during Wednesday’s session following yesterday’s earnings beat. According to some analysts, the company...

To read the full story on AllPennyStocks.com, click here.

Heron Therapeautics (NASDAQ:HRTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Heron Therapeautics Charts.

Heron Therapeautics (NASDAQ:HRTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Heron Therapeautics Charts.

News Heron Therapeautics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
Dienstag 7 Mai 2024 (2 Wochen vor) • PR Newswire (US)

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Mittwoch 24 April 2024 (3 Wochen vor) • PR Newswire (US)

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Donnerstag 11 April 2024 (1 Monat vor) • PR Newswire (US)

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Donnerstag 28 März 2024 (2 Monate vor) • PR Newswire (US)

Biotech Finds Mid-Week Success Following Q4 Earnings Release
Mittwoch 13 März 2024 (2 Monate vor) • AllPennyStocks.com

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
Dienstag 12 März 2024 (2 Monate vor) • PR Newswire (US)

Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading
Dienstag 12 März 2024 (2 Monate vor) • IH Market News

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
Mittwoch 28 Februar 2024 (3 Monate vor) • PR Newswire (US)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Heron Therapeautics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen